ReviewFrontiers in immunology2024

Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine.

Janosch Railton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.